
Respipure Pharma Private Limited
Manufactures and sells various pharmaceutical and healthcare products.
Manufactures and sells various pharmaceutical and healthcare products.
Respipure Pharma Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 January 2022 (Three years and one month 12 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹72.18 Cr.
Manish Mangilal, Nishant Vaish, and Shekhar Bhuwania serve as directors at the Company.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U24290MH2022PTC375528
375528
Private Limited Indian Non-Government Company
27 Jan 2022
30 Sep 2024
31 Mar 2024
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shekhar Bhuwania ![]() | Director | 15-Jun-2022 | Current |
Manish Mangilal ![]() | Director | 27-Jan-2022 | Current |
Nishant Vaish ![]() | Director | 27-Jan-2022 | Current |
Respipure Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2023, Respipure Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Shekhar Bhuwania is a mutual person
Shekhar Bhuwania is a mutual person
Shekhar Bhuwania is a mutual person
Shekhar Bhuwania is a mutual person
Manish Mangilal is a mutual person
Manish Mangilal is a mutual person
₹72.18 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
18 Oct 2023 | Hdfc Bank Limited | ₹33.54 Cr | Open |
19 Dec 2022 | Hdfc Bank Limited | ₹38.64 Cr | Open |
Respipure Pharma has a workforce of 0 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Respipure Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Respipure Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Respipure Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
A charge with Hdfc Bank Limited of Rs. 38.64 Cr registered on 19 Dec 2022 with Charge ID 100657340 was modified on 05 Jul 2024.
A charge with Hdfc Bank Limited of Rs. 33.54 Cr registered on 18 Oct 2023 with Charge ID 100806250 was modified on 02 Apr 2024.
Respipure Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
A charge with Hdfc Bank Limited amounted to Rs. 33.54 Cr with Charge ID 100806250 was registered on 18 Oct 2023.
A charge with Hdfc Bank Limited amounted to Rs. 38.64 Cr with Charge ID 100657340 was registered on 19 Dec 2022.
Respipure Pharma Private Limited was incorporated on 27 Jan 2022.
The authorized share capital of Respipure Pharma Private Limited is ₹ 5.50 Cr and paid-up capital is ₹ 1.00 Cr.
Currently 3 directors are associated with Respipure Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Respipure Pharma Private Limited is Shop-75 Floor-7Th Plot-215 Free Press House Press Journal Marg, Nariman Point India, Mumbai, Maharashtra, 400021.
The corporate identification number (CIN) of Respipure Pharma Private Limited is U24290MH2022PTC375528 and the company number is 375528 as per Ministry of Corporate Affairs (MCA).
As per the financial statements for fiscal Year 2023, The total open charges for Respipure Pharma Private Limited amount to ₹ 72.18 Cr.
The most recent Balance Sheet for Respipure Pharma Private Limited was filed with the ROC on 31 Mar 2024.